RxDoctor Payments DataLook up a doctor →

Paul Schorr

Medical · Canal Winchester, OHNPI 1063546828

Payments from drug & device makers

$5,915in general payments, 2019–2025

Across 501 payments — averaging $11.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$628
  • Bayer$568
  • Pfizer$383
  • Biohaven Pharmaceuticals, Inc.$286
  • Takeda Pharmaceuticals U.S.A., Inc.$221
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$5,86399%
  • Education$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,915 in reported general payments places this provider in the 90th percentile of 547 medical providers in Ohio.

See all medical providers in Ohio

Medicare billing

Part B allowed, 2024
$65,398
Medicare patients
164
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin106$85,248
EliquisApixaban56$55,764
OzempicSemaglutide42$49,265
XareltoRivaroxaban48$38,238
RybelsusSemaglutide19$30,052
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr48$26,928
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$22,211
LinzessLinaclotide32$21,928
JanuviaSitagliptin Phosphate19$21,585
VraylarCariprazine Hcl12$16,474
KerendiaFinerenone18$14,070
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$12,166
Bevespi AerosphereGlycopyrrolate/Formoterol Fum24$10,513
Soliqua 100-33Insulin Glargine/Lixisenatide12$10,053
Emgality PenGalcanezumab-Gnlm12$8,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Pradaxa$185$87,326117 claims
Novo NordiskOzempic, Rybelsus$628$79,31761 claims
PfizerEliquis$383$55,76456 claims
GSKAnoro Ellipta, Trelegy Ellipta$190$49,13978 claims
AbbVieLinzess, Vraylar$1,218$38,40244 claims
BayerKerendia$568$14,07018 claims
AstraZenecaBevespi Aerosphere$184$10,51324 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$14$10,05312 claims
Astellas Pharma US IncMyrbetriq$194$8,09112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 547 medical providers in Ohio.

Other medical in Canal Winchester

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →